These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977 [TBL] [Abstract][Full Text] [Related]
50. Susceptibility-weighted imaging for cerebral microbleed detection in super-acute ischemic stroke patients treated with intravenous thrombolysis. Bai Q; Zhao Z; Sui H; Xie X; Chen J; Yang J; Zhang L Neurol Res; 2013 Jul; 35(6):586-93. PubMed ID: 23561793 [TBL] [Abstract][Full Text] [Related]
51. NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population. Nacu A; Kvistad CE; Naess H; Øygarden H; Logallo N; Assmus J; Waje-Andreassen U; Kurz KD; Neckelmann G; Thomassen L Stroke; 2017 Feb; 48(2):335-341. PubMed ID: 27980128 [TBL] [Abstract][Full Text] [Related]
52. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776 [TBL] [Abstract][Full Text] [Related]
53. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort. Cronin CA; Langenberg P; Dutta TM; Kittner SJ Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551 [TBL] [Abstract][Full Text] [Related]
54. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Manawadu D; Bodla S; Keep J; Jarosz J; Kalra L Stroke; 2013 Feb; 44(2):427-31. PubMed ID: 23287781 [TBL] [Abstract][Full Text] [Related]
55. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554 [TBL] [Abstract][Full Text] [Related]
56. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack. Alonso de Leciñana M; Fuentes B; Masjuan J; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Egido JA Int J Stroke; 2012 Apr; 7(3):213-8. PubMed ID: 22098785 [TBL] [Abstract][Full Text] [Related]
57. Internal cerebral vein asymmetry on follow-up brain computed tomography after intravenous thrombolysis in acute anterior circulation ischemic stroke is associated with poor outcome. Sharma VK; Yeo LL; Teoh HL; Shen L; Chan BP; Seet RC; Ahmad A; Chong VF; Paliwal PR J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):e39-45. PubMed ID: 24119628 [TBL] [Abstract][Full Text] [Related]
58. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke. Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539 [TBL] [Abstract][Full Text] [Related]
59. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC; Rabinstein AA Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870 [TBL] [Abstract][Full Text] [Related]
60. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Yamaguchi T; Mori E; Minematsu K; Nakagawara J; Hashi K; Saito I; Shinohara Y; Stroke; 2006 Jul; 37(7):1810-5. PubMed ID: 16763187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]